Alnylam Pharmaceuticals, Inc.

SUSQUEHANNA INTERNATIONAL GROUP, LLP ALNY

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/17/2026

Shares

191,820

Value ($000)

76,277

Weight

0.1%

2013 Q4 - 2025 Q4 (27 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/17/2026	76,277	0.1%	191,820	12/31/2025
2025 Q3	11/14/2025	263,400	0.4%	577,632	9/30/2025
2025 Q2	8/14/2025	67,912	0.1%	208,262	6/30/2025
2025 Q1	5/14/2025	19,027	0.0%	70,465	3/31/2025
2024 Q4	2/14/2025	2,545	0.0%	10,817	12/31/2024
2024 Q3	11/14/2024	45,032	0.1%	163,734	9/30/2024
2024 Q2	8/15/2024	16,284	0.0%	67,011	6/30/2024
2024 Q1	5/7/2024	12,204	0.0%	81,662	3/31/2024
2023 Q4	2/14/2024	4,978	0.0%	26,007	12/31/2023
2023 Q3	11/14/2023	33,357	0.1%	188,353	9/30/2023
2023 Q2	8/11/2023	17,005	0.0%	89,530	6/30/2023
2023 Q1	5/16/2023	22,917	0.0%	114,401	3/31/2023
2022 Q4	2/14/2023	7,288	0.0%	30,665	12/31/2022
2022 Q3	11/14/2022	8,490	0.0%	42,417	9/30/2022
2022 Q2	8/15/2022	9,251	0.0%	63,428	6/30/2022
2022 Q1	5/16/2022	13,675	0.0%	83,747	3/31/2022
2021 Q4	2/14/2022	24,242	0.0%	142,955	12/31/2021
2021 Q3	11/15/2021	8,382	0.0%	44,393	9/30/2021
2021 Q2	8/11/2021	18,339	0.0%	108,181	6/30/2021
2021 Q1	5/17/2021	9,414	0.0%	66,674	3/31/2021
2020 Q4	2/16/2021	10,258	0.0%	78,928	12/31/2020
2020 Q3	11/16/2020	5,564	0.0%	38,219	9/30/2020
2020 Q2	8/14/2020	1,885	0.0%	12,726	6/30/2020
2020 Q1	5/15/2020	4,232	0.0%	38,879	3/31/2020
2019 Q4	2/14/2020	4,432	0.0%	38,477	12/31/2019
2014 Q1	5/14/2014	3,820	0.0%	56,885	3/31/2014
2013 Q4	2/13/2014	3,875	0.0%	60,234	12/31/2013